Mantur M, Matowicka-Karna J, Darewicz B, Kemona H, Dymicka-Piekarska V, Prokopowicz J, Darewicz J
Institute of Laboratory Diagnostics, Medical Academy of Białystok.
Rocz Akad Med Bialymst. 1998;43:194-200.
The activity of granulocytic myeloperoxidase (MPO) was investigated in 45 patients with renal cancer before and 14 days after renal artery embolization in comparison with control group of 40 healthy people. The group examined showed lower MPO activity before embolization, as compared to controls. The differences being statistical insignificant (p > 0.05). After embolization the activity MPO was normalized, reaching the mean value of control group. The findings revealed reduced granulocytic MPO activity in patients with renal cancer.
对45例肾癌患者在肾动脉栓塞术前及栓塞后14天的粒细胞髓过氧化物酶（MPO）活性进行了研究，并与40名健康人的对照组进行比较。与对照组相比，所检查的组在栓塞术前MPO活性较低。差异无统计学意义（p>0.05）。栓塞后MPO活性恢复正常，达到对照组的平均值。研究结果显示肾癌患者粒细胞MPO活性降低。
